Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Milan Radovich, PhD, on Predicting Relapse in Patients With Triple-Negative Breast Cancer

Posted: Thursday, December 19, 2019

Milan Radovich, PhD, of Indiana University School of Medicine, discusses the practical challenges of using circulating tumor DNA tests in the clinic to predict which patients with triple-negative disease will relapse.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.